Worldwide Industry for Biopreservation to 2026 - Key Drivers, Restraints and Opportunities

DUBLIN, Jan. 4, 2021 /PRNewswire/ -- The "Biopreservation Market by Type, Application, End-user, and Geography - Global Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.

Biopreservation is a process that assists in the conservation of biospecimens such as DNA, saliva, and plasma. This process of biopreservation generally increases the durability, shelf life, and purity of the biosamples. The types of equipment in this process include freezers, liquid nitrogen, consumables, and also media & laboratory information management systems.

This process is also used to preserve food and extend its shelf life, specifically by using lactic acid bacteria. Growth in healthcare spending is assumed for better access to quality healthcare and advanced technology products such as biopreservation facilities, thereby widening the growth expectations. Moreover, the bio-banks, hospitals, and gene banks, which are major end-users for this market, are stimulating the key providers to establish technologically advanced biopreservation products to improve patient outcomes. The Biopreservation Market is projected to grow at a rate of 9.2% CAGR by 2026.

The biopreservation market has been analyzed by utilizing the optimum combination of secondary sources and in-house methodology, along with an irreplaceable blend of primary insights. The real-time assessment of the market is an integral part of our market sizing and forecasting methodology. Our industry experts and panel of primary participants have helped in compiling relevant aspects with realistic parametric estimations for a comprehensive study. The participation share of different categories of primary participants is given below:

In the market for biopreservation, the application of biopreservation consists of therapeutic applications, research applications, clinical trials, and other applications. The biopreservation is primarily applied in therapeutics due to the advancements in regenerative medicine & customized medicine, an increase in the shift of cord blood banking, and the rising incidence of chronic diseases.

The end-users of the biopreservation market include biobanks, gene banks, hospitals, and other end users. The biobanks segment is expected to have a major share in the market. The major share of this segment is attributed to the increasing preference for the preservation of stem cells and the rising numbers of sperm and egg banks.

Further, according to the regional market of biopreservation, the North American region is recorded for the colossal share in the market. This is due to the continuous drug developments and the arrival of advanced therapies in the domain of biomedical research. Additionally, the increasing requirement of expensive and improved treatment for patients' chronic diseases is the key factor.

The rising incidence of chronic diseases, including cardiac, renal diseases, diabetes, and obesity, is the crucial factor that will propel the biopreservation market growth in the prevailing period. Government initiatives to encourage stem cell therapies to treat the disease, which will again propel market growth. Conversely, the strict regulations for producing biopreservation products and the evolution of room temperature storage procedures may limit the biopreservation market growth.

Merck KGaA, Avantor, Inc., Bio-Techne Corporation, BioLife Solutions, Inc., Thermo Fisher Scientific Inc, ThermoGenesis Holdings, Inc., Worthington Industries, Inc., Chart Industries, Inc, So-Low Environmental Equipment Co., Inc., Princeton BioCision, LLC, Shanghai Genext Medical Technology Co. Ltd, Exact Sciences Corporation, Helmer Scientific, Inc., CryoTech, Inc., Arctiko, Nippon Genetics Europe, PHC Holdings Corporation, STEMCELL Technologies, Inc., AMS Biotechnology, and OPS Diagnostics. These are the few companies list of the biopreservation market.

Since the rapid increase in the number of research and developments gives the way of potentials for market growth, the biopreservation of biological samples has become a crucial segment. This helps the researchers to access the data of the number of people by the preserved biological samples.

This research presents a thorough analysis of market share, the present trends, and forthcoming evaluations to explain the approaching investment pockets.

This research provides market insights from 2020 to 2026, which is predicted to allow the shareholders to capitalize on the forthcoming opportunities.

This report further offers comprehensive insights into the region, which helps to understand the geographical market and assist in strategic business planning and ascertain future opportunities.

Key Topics Covered:

1. Executive Summary

2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends

3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. PEST Analysis
3.2.2. Porter Five Forces
3.3. Related Markets

4. Market characteristics
4.1. Market Evolution
4.2. Market Trends and Impact
4.3. Advantages/Disadvantages of Market
4.4. Regulatory Impact
4.5. Market Offerings
4.6. Market Segmentation
4.7. Market Dynamics
4.7.1. Drivers
4.7.2. Restraints
4.7.3. Opportunities
4.8. DRO - Impact Analysis

5. Type: Market Size & Analysis
5.1. Overview
5.2. Biopreservation Media
5.2.1. Nutrient Media
5.2.2. Sera
5.2.3. Growth Factors & Supplements
5.3. Biospecimen Equipment
5.3.1. Temperature Control Systems
5.4. Freezers
5.5. Cryogenic Storage Systems
5.6. Thawing Equipment
5.7. Refrigerators
5.7.1. Accessories
5.7.2. Alarms & Monitoring systems
5.7.3. Incubators
5.7.4. Centrifuges
5.7.5. Other Equipment

6. Application: Market Size & Analysis
6.1. Overview
6.2. Therapeutic Applications
6.3. Research Applications
6.4. Clinical Trials
6.5. Other Applications

7. End User: Market Size & Analysis
7.1. Overview
7.2. Biobanks
7.3. Gene Banks
7.4. Hospitals
7.5. Other End Users

8. Geography: Market Size & Analysis
8.1. Overview
8.2. North America
8.3. Europe
8.4. Asia Pacific
8.5. Rest of the World

9. Competitive Landscape
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
9.2.2. Product Launches and execution

10. Vendor Profiles
10.1. Merck KGaA
10.1.1. Overview
10.1.2. Financials
10.1.3. Products & Services
10.1.4. Recent Developments
10.1.5. Business Strategy
10.2. Avantor, Inc
10.2.1. Overview
10.2.2. Financials
10.2.3. Products & Services
10.2.4. Recent Developments
10.2.5. Business Strategy
10.3. Bio-Techne Corporation
10.3.1. Overview
10.3.2. Financials
10.3.3. Products & Services
10.3.4. Recent Developments
10.3.5. Business Strategy
10.4. BioLife Solutions, Inc
10.4.1. Overview
10.4.2. Financials
10.4.3. Products & Services
10.4.4. Recent Developments
10.4.5. Business Strategy
10.5. Thermo Fisher Scientific Inc
10.5.1. Overview
10.5.2. Financials
10.5.3. Products & Services
10.5.4. Recent Developments
10.5.5. Business Strategy
10.6. ThermoGenesis Holdings, Inc
10.6.1. Overview
10.6.2. Financials
10.6.3. Products & Services
10.6.4. Recent Developments
10.6.5. Business Strategy
10.7. Worthington Industries, Inc
10.7.1. Overview
10.7.2. Financials
10.7.3. Products & Services
10.7.4. Recent Developments
10.7.5. Business Strategy
10.8. Chart Industries, Inc
10.8.1. Overview
10.8.2. Financials
10.8.3. Products & Services
10.8.4. Recent Developments
10.8.5. Business Strategy
10.9. So-Low Environmental Equipment Co.,Inc
10.9.1. Overview
10.9.2. Financials
10.9.3. Products & Services
10.9.4. Recent Developments
10.9.5. Business Strategy
10.10. Princeton BioCision, LLC
10.10.1. Overview
10.10.2. Financials
10.10.3. Products & Services
10.10.4. Recent Developments
10.10.5. Business Strategy

11. Companies to Watch
11.1. Shanghai Genext Medical Technology Co. Ltd
11.1.1. Overview
11.1.2. Products & Services
11.1.3. Business Strategy
11.2. Exact Sciences Corporation
11.2.1. Overview
11.2.2. Products & Services
11.2.3. Business Strategy
11.3. Helmer Scientific, Inc
11.3.1. Overview
11.3.2. Products & Services
11.3.3. Business Strategy
11.4. CryoTech, Inc
11.4.1. Overview
11.4.2. Products & Services
11.4.3. Business Strategy
11.5. Arctiko
11.5.1. Overview
11.5.2. Products & Services
11.5.3. Business Strategy
11.6. Nippon Genetics Europe
11.6.1. Overview
11.6.2. Products & Services
11.6.3. Business Strategy
11.7. PHC Holdings Corporation
11.7.1. Overview
11.7.2. Products & Services
11.7.3. Business Strategy
11.8. STEMCELL Technologies, Inc
11.8.1. Overview
11.8.2. Products & Services
11.8.3. Business Strategy
11.9. AMS Biotechnology
11.9.1. Overview
11.9.2. Products & Services
11.9.3. Business Strategy
11.10. OPS Diagnostics
11.10.1. Overview
11.10.2. Products & Services
11.10.3. Business Strategy

12. Analyst Opinion

13. Annexure
13.1. Report Scope
13.2. Market Definitions
13.3. Research Methodology
13.3.1. Data Collation and In-house Estimation
13.3.2. Market Triangulation
13.3.3. Forecasting
13.4. Report Assumptions
13.5. Declarations
13.6. Stakeholders
13.7. Abbreviations

For more information about this report visit https://www.researchandmarkets.com/r/711zgr

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com